Eleonora M.C. Trecca

Prof. Eleonora M.C. Trecca

Otolaryngology, University of Foggia, Foggia, Puglia, Italy
orcid
Associate Professor of Otolaryngology

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
Luigi Angelo VairaLuigi Angelo Vaira
Luigi Angelo Vaira
JLJerome R. Lechien
Jerome R. Lechien
VAVincenzo Abbate
Vincenzo Abbate
FAFabiana Allevi
Fabiana Allevi
GAGiovanni Audino
Giovanni Audino
GRGiacomo De Riu
Giacomo De Riu
Background: The widespread diffusion of Artificial Intelligence (AI) platforms is revolutionizing how health-related information is disseminated, thereby highlighting the need for tools to evaluate the quality of such information. This study aimed to propose and validate the Quality Assessment of Medical Artificial Intelligence (QAMAI), a tool specifically designed to assess the quality of health information provided by AI platforms. Methods: The QAMAI tool has been developed by a panel of experts following guidelines for the development of new questionnaires. A total of 30 responses from ChatGPT4, addressing patient queries, theoretical questions, and clinical head and neck surgery scenarios were assessed by 27 reviewers from 25 academic centers worldwide. Construct validity, internal consistency, inter-rater and test–retest reliability were assessed to validate the tool. Results: The validation was conducted on the basis of 792 assessments for the 30 responses given by ChatGPT4. The results of the exploratory factor analysis revealed a unidimensional structure of the QAMAI with a single factor comprising all the items that explained 51.1% of the variance with factor loadings ranging from 0.449 to 0.856. Overall internal consistency was high (Cronbach's alpha = 0.837). The Interclass Correlation Coefficient was 0.983 (95% CI 0.973–0.991; F (29,542) = 68.3; p < 0.001), indicating excellent reliability. Test–retest reliability analysis revealed a moderate-to-strong correlation with a Pearson’s coefficient of 0.876 (95% CI 0.859–0.891; p < 0.001). Conclusions: The QAMAI tool demonstrated significant reliability and validity in assessing the quality of health information provided by AI platforms. Such a tool might become particularly important/useful for physicians as patients increasingly seek medical information on AI platforms.

6 January 2021 in The Laryngoscope
Verified
Journal Article
Open access
PDF file
ANAndreas Steenholt Niklassen
Andreas Steenholt Niklassen
JDJulia Draf
Julia Draf
CHCaroline Huart
Caroline Huart
CHConstantin Hintschich
Constantin Hintschich
SBSimone Bocksberger
Simone Bocksberger
THThomas Hummel
Thomas Hummel
Objective/Hypothesis: With the COVID‐19 pandemic, chemosensory dysfunction are among the most prevalent symptoms. Most reports are subjective evaluations, which have been suggested to be unreliable. The objective is to test chemosensory dysfunction and recovery based on extensive psychophysical tests in COVID‐19 during the course of the disease.Study Design: Prospective cohort study.Methods: A total of 111 patients from four centers participated in the study. All tested positive for SARS‐COV‐2 with RT‐PCR. They were tested within 3 days of diagnosis and 28 to 169 days after infection. Testing included extensive olfactory testing with the Sniffin' Sticks test for threshold, discrimination and identification abilities, and with the Taste Sprays and Taste Strips for gustatory function for quasi‐threshold and taste identification abilities.Results: There was a significant difference in olfactory function during and after infection. During infection 21% were anosmic, 49% hyposmic, and 30% normosmic. After infection only 1% were anosmic, 26% hyposmic, and 73% normosmic. For gustatory function, there was a difference for all taste qualities, but significantly in sour, bitter, and total score. Twenty‐six percent had gustatory dysfunction during infection and 6.5% had gustatory dysfunction after infection. Combining all tests 22% had combined olfactory and gustatory dysfunction during infection. After infection no patients had combined dysfunction.Conclusions: Chemosensory dysfunction is very common in COVID‐19, either as isolated smell or taste dysfunction or a combined dysfunction. Most people regain their chemosensory function within the first 28 days, but a quarter of the patients show persisting dysfunction, which should be referred to specialist smell and taste clinics for rehabilitation of chemosensory function.Level of Evidence: 3 Laryngoscope, 131:1095–1100, 2021

1 March 2022 in Journal of Voice
Verified
Journal Article
Closed access
Jerome R. LechienJerome R. Lechien
Jerome R. Lechien
CCCarlos M. Chiesa-Estomba
Carlos M. Chiesa-Estomba
PCPierre Cabaraux
Pierre Cabaraux
QMQuentin Mat
Quentin Mat
KHKathy Huet
Kathy Huet
Sven SaussezSven Saussez
Sven Saussez

1 December 2020 in Rhinology journal
Verified
Journal Article
Closed access
CHC. Huart
C. Huart
CPC. Philpott
C. Philpott
IKI. Konstantinidis
I. Konstantinidis
AAA. Altundag
A. Altundag
KWK.L. Whitcroft
K.L. Whitcroft
THT. Hummel
T. Hummel
Anosmia constitutes a prominent symptom of COVID-19. However, anosmia is also a common symptom of acute colds of various origins. In contrast to an acute cold, it appears from several questionnaire-based studies that in the context of COVID-19 infection, anosmia is the main rhinological symptom and is usually not associated with other rhinological symptoms such as rhinorrhoea or nasal obstruction. Until now, no study has directly compared smell and taste function between COVID-19 patients and patients with other causes of upper respiratory tract infection (URTI) using valid and reliable psychophysical tests. In this study, we aimed to objectively assess and compare olfactory and gustatory functions in 10 COVID-19 patients (PCR diagnosed, assessed on average 2 weeks after infection), 10 acute cold (AC) patients (assessed before the COVID-19 outbreak) and 10 healthy controls, matched for age and sex. Smell performance was assessed using the extended "Sniffin' Sticks" test battery (4), while taste function was assessed using "taste strips" (5). Receiver Operating Characteristic (ROC) curves were built to probe olfactory and gustatory scores in terms of their discrimination between COVID-19 and AC patients. Our results suggest that mechanisms of COVID-19 related olfactory dysfunction are different from those seen in an AC and may reflect, at least to some extent, a specific involvement at the level of central nervous system in some COVID-19 patients. In the future, studies to assess the prevalence of persistent anosmia and neuroanatomical changes on MRI correlated to chemosensory function, will be useful to understand these mechanisms.

1 July 2020 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
Eleonora M.C. TreccaEleonora M.C. Trecca
Eleonora M.C. Trecca
MGMatteo Gelardi
Matteo Gelardi
MCMichele Cassano
Michele Cassano

25 July 2020 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MBMaria Rosaria Barillari
Maria Rosaria Barillari
LBLuca Bastiani
Luca Bastiani
Jerome R. LechienJerome R. Lechien
Jerome R. Lechien
GMGiuditta Mannelli
Giuditta Mannelli
GMGabriele Molteni
Gabriele Molteni
GCGiovanni Cammaroto
Giovanni Cammaroto